Our research

May 2022

Addenbrooke’s hospital is part of six NHS brain cancer centres to be awarded excellence status by the Tessa Jowell Brain Cancer Mission.

May 2022

A multi-million pound trial has been announced to pave the way for the Cytosponge test to become a routine screening programme, to help detect early signs of oesophageal cancer.

April 2022

Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of more than 50 new potential causes of cancer.

March 2022

Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to researchers at the University of Cambridge.

February 2022

Addenbrooke's oncologist Professor Charlotte Coles is to lead an international multidisciplinary team aiming to influence global policy and improve the lives of people at risk of, and living with, breast cancer.